Evidence map›Paper›PMID 38006067›Full record

ArticlePolymers2023

Nanocarrier of α-Tocopheryl Succinate Based on a Copolymer Derivative of (4,7-dichloroquinolin-2-yl)methanol and Its Cytotoxicity against a Breast Cancer Cell Line.

Hernán Valle, Raquel Palao-Suay, María Rosa Aguilar, Tulio A Lerma, Manuel Palencia, Ramalinga Viswanathan Mangalaraja, Leonardo Guzmán, Dairo Pérez Sotelo, José Becerra

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Hernán ValleChemistry Department, Faculty of Basic Sciences, University of Córdoba, Montería 230002, Colombia.
Raquel Palao-SuayGroup of Biomaterials, Department of Polymeric Nanomaterials and Biomaterials, Institute of Polymer Science and Technology, Spanish National Research Council (ICTP-CSIC), 28006 Madrid, Spain.
María Rosa AguilarGroup of Biomaterials, Department of Polymeric Nanomaterials and Biomaterials, Institute of Polymer Science and Technology, Spanish National Research Council (ICTP-CSIC), 28006 Madrid, Spain.ORCID 0000-0001-7395-5754
Tulio A LermaResearch Group in Science with Technological Applications (GI-CAT), Department of Chemistry, Faculty of Natural and Exact Science, University of Valle, Cali 760042, Colombia.ORCID 0000-0002-3799-0285
Manuel PalenciaResearch Group in Science with Technological Applications (GI-CAT), Department of Chemistry, Faculty of Natural and Exact Science, University of Valle, Cali 760042, Colombia.ORCID 0000-0003-0641-9040
Ramalinga Viswanathan MangalarajaFaculty of Engineering and Sciences, Adolfo Ibáñez University, Diagonal Las Torres 2640, Peñalolén, Santiago 7941169, Chile.ORCID 0000-0003-1016-9830
Leonardo GuzmánLaboratory of Molecular Neurobiology, Department of Physiology, Faculty of Biological Sciences, University of Concepción, Casilla 160-C, Concepción 4070386, Chile.
Dairo Pérez SoteloChemistry Department, Faculty of Basic Sciences, University of Córdoba, Montería 230002, Colombia.
José BecerraLaboratory of Chemistry of Natural Products, Department of Botany, Faculty of Natural and Oceanographic Sciences, University of Concepción, Casilla 160-C, Concepción 4070386, Chile.
University of Concepción · CLConsejo Superior de Investigaciones Científicas · ESAdolfo Ibáñez University · CLNIHR MindTech MedTech Co-operative · GBUniversidad del Valle · COUniversity of Córdoba · CO

Funding

Agencia Nacional de Investigación y Desarrollo ANID Fondecyt Iniciación 11191065
6 · The paper itself

Abstract

In order to improve the water solubility and, therefore, bioavailability and therapeutic activity of anticancer hydrophobic drug α-tocopherol succinate (α-TOS), in this work, copolymers were synthesized via free radicals from QMES (1-[4,7-dichloroquinolin-2-ylmethyl]-4-methacryloyloxyethyl succinate) and VP (N-vinyl-2-pirrolidone) using different molar ratios, and were used to nanoencapsulate and deliver α-TOS into cancer cells MCF-7. QMES monomer was chosen because the QMES pendant group in the polymer tends to hydrolyze to form free 4,7-dichloro-2-quinolinemethanol (QOH), which also, like α-TOS, exhibit anti-proliferative effects on cancerous cells. From the QMES-VP 30:70 (QMES-30) and 40:60 (QMES-40) copolymers obtained, it was possible to prepare aqueous suspensions of empty nanoparticles (NPs) loaded with α-TOS by nanoprecipitation. The diameter and encapsulation efficiency (%EE) of the QMES-30 NPs loaded with α-TOS were 128.6 nm and 52%; while for the QMES-40 NPs loaded with α-TOS, they were 148.8 nm and 65%. The results of the AlamarBlue assay at 72 h of treatment show that empty QMES-30 NPs (without α-TOS) produced a marked cytotoxic effect on MCF-7 breast cancer cells, corresponding to an IC

Indexed as

anticancerbiomedical applicationscopolymersnanoparticlesradical polymerizationself-assembly

Identifiers

PMID38006067
PMCPMC10674486
OpenAlexW4388465431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.